Physician profile
Jay C Lambert
NPI 1770677478
$413.96
in general payments reported to CMS, 2019-2025
14 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $53.47 · 2024: $83.90 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.57 | 2022 | |
| Janssen Pharmaceuticals, INC | $53.47 | 2023 | Spravato |
| Abbvie INC. | $35.64 | 2025 | |
| Novo Nordisk INC | $34.31 | 2024-2025 | Ozempic |
| Lilly USA, LLC | $34.04 | 2024-2025 | Mounjaro |
| Boston Scientific Corporation | $20.49 | 2025 | Wavewriter Alpha Prime 16 |
| Insmed, INC. | $19.31 | 2024 | Arikayce |
| Merck Sharp & Dohme LLC | $18.54 | 2025 | Gardasil 9, Capvaxive |
| Corium, LLC | $18.02 | 2025 | Azstarys |
| Medtronic, INC. | $17.62 | 2025 | Inceptiv |
| Glaxosmithkline, LLC. | $17.56 | 2025 | Shingrix |
| Inspire Medical Systems, INC. | $14.82 | 2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $14.07 | 2024 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.50 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.